D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 54,888 342 World Ranking 10668 National Ranking 1007

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Diabetes mellitus

His primary areas of investigation include Genetics, Internal medicine, Type 2 diabetes, Endocrinology and Single-nucleotide polymorphism. His work in Internal medicine covers topics such as Genotype which are related to areas like Allele, Coding region and Missense mutation. His study looks at the relationship between Type 2 diabetes and fields such as TCF7L2, as well as how they intersect with chemical problems.

His Endocrinology course of study focuses on Risk factor and SH2B1. His Single-nucleotide polymorphism research is multidisciplinary, incorporating perspectives in Polymorphism, Allele frequency and Human genetics. His studies in Obesity integrate themes in fields like Body mass index, FTO gene and Birth weight.

His most cited work include:

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (7922 citations)
  • A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity (3415 citations)
  • A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity (3415 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Diabetes mellitus, Endocrinology, Genetics and Type 2 diabetes. His Internal medicine study frequently draws connections to other fields, such as Genotype. While the research belongs to areas of Diabetes mellitus, Graham A. Hitman spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Coeliac disease.

His Endocrinology research incorporates themes from Receptor and Candidate gene. Locus, Allele, Haplotype, Single-nucleotide polymorphism and Gene are subfields of Genetics in which his conducts study. His Type 2 diabetes research incorporates elements of Odds ratio, Case-control study, TCF7L2, Genetic association and Insulin resistance.

He most often published in these fields:

  • Internal medicine (42.17%)
  • Diabetes mellitus (36.18%)
  • Endocrinology (33.33%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (42.17%)
  • Pregnancy (6.84%)
  • Diabetes mellitus (36.18%)

In recent papers he was focusing on the following fields of study:

Graham A. Hitman focuses on Internal medicine, Pregnancy, Diabetes mellitus, Type 2 diabetes and Endocrinology. Graham A. Hitman has researched Internal medicine in several fields, including Single-nucleotide polymorphism and Bioinformatics. He combines subjects such as Psychological intervention, Obesity and Pediatrics with his study of Pregnancy.

His Diabetes mellitus study combines topics in areas such as Clinical trial and Vitamin B12. Graham A. Hitman has included themes like Human physiology, Metabolic syndrome and Insulin resistance in his Type 2 diabetes study. His biological study spans a wide range of topics, including Receptor, Downregulation and upregulation, Randomized controlled trial and DNA methylation.

Between 2013 and 2021, his most popular works were:

  • Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials (357 citations)
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)
  • Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial (135 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Diabetes mellitus

Graham A. Hitman mostly deals with Internal medicine, Endocrinology, Type 2 diabetes, Pregnancy and Diabetes mellitus. His studies deal with areas such as Transcription factor and Programmed cell death as well as Internal medicine. His Endocrinology study combines topics from a wide range of disciplines, such as Microarray analysis techniques, Downregulation and upregulation, Gene knockdown and DNA methylation.

The various areas that Graham A. Hitman examines in his Type 2 diabetes study include Human physiology, Overweight and Metabolic syndrome. Graham A. Hitman has researched Diabetes mellitus in several fields, including Ophthalmology and Visual acuity. His Cholesterol research includes themes of Gastroenterology, Genome-wide association study, Diabetic angiopathy and C-reactive protein.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock.
Nature (2007)

8473 Citations

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Timothy M. Frayling;Nicholas J. Timpson;Michael N. Weedon;Eleftheria Zeggini;Eleftheria Zeggini;Eleftheria Zeggini.
Science (2007)

6774 Citations

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M Colhoun;D John Betteridge;Paul N Durrington;Graham A Hitman.
The Lancet (2004)

5616 Citations

Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes

Eleftheria Zeggini;Michael N. Weedon;Cecilia M. Lindgren;Timothy M. Frayling.
Science (2007)

2594 Citations

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

E Zeggini;L J Scott;R Saxena;B F Voight.
Nature Genetics (2008)

2180 Citations

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Benjamin F. Voight;Benjamin F. Voight;Laura J. Scott;Valgerdur Steinthorsdottir;Andrew P. Morris.
Nature Genetics (2010)

2041 Citations

A genome-wide association search for type 2 diabetes genes in African Americans.

N D Palmer;C W McDonough;P J Hicks;B H Roh.
PLOS ONE (2012)

1784 Citations

GERMLINE MUTATIONS IN THE EXTRACELLULAR DOMAINS OF THE 55 KDA TNF RECEPTOR, TNFR1, DEFINE A FAMILY OF DOMINANTLY INHERITED AUTOINFLAMMATORY SYNDROMES

Michael F McDermott;Ivona Aksentijevich;Jérôme Galon;Elizabeth M McDermott.
Cell (1999)

1457 Citations

Genome-wide association study identifies eight loci associated with blood pressure

Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin.
Nature Genetics (2009)

1383 Citations

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock.
Nature Genetics (2007)

1329 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Graham A. Hitman

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 378

Leif Groop

Leif Groop

Lund University

Publications: 264

Philippe Froguel

Philippe Froguel

Imperial College London

Publications: 262

Oluf Pedersen

Oluf Pedersen

University of Copenhagen

Publications: 262

Torben Hansen

Torben Hansen

University of Copenhagen

Publications: 243

Hakon Hakonarson

Hakon Hakonarson

Children's Hospital of Philadelphia

Publications: 181

Albert Hofman

Albert Hofman

Harvard University

Publications: 179

Eric Boerwinkle

Eric Boerwinkle

The University of Texas Health Science Center at Houston

Publications: 177

André G. Uitterlinden

André G. Uitterlinden

Erasmus University Rotterdam

Publications: 176

Ruth J. F. Loos

Ruth J. F. Loos

University of Copenhagen

Publications: 171

Jose C. Florez

Jose C. Florez

Harvard University

Publications: 168

Nilesh J. Samani

Nilesh J. Samani

University of Leicester

Publications: 164

Paul W. Franks

Paul W. Franks

Lund University

Publications: 163

Joel N. Hirschhorn

Joel N. Hirschhorn

Boston Children's Hospital

Publications: 163

Jerome I. Rotter

Jerome I. Rotter

UCLA Medical Center

Publications: 158

Bruce M. Psaty

Bruce M. Psaty

University of Washington

Publications: 157

Trending Scientists

John H. Holland

John H. Holland

University of Michigan–Ann Arbor

Herbert Zirath

Herbert Zirath

Chalmers University of Technology

B. Montgomery Pettitt

B. Montgomery Pettitt

The University of Texas Medical Branch at Galveston

Lin Gan

Lin Gan

Huazhong University of Science and Technology

Hannah J. Joyce

Hannah J. Joyce

University of Cambridge

Boris Schröder

Boris Schröder

Technische Universität Braunschweig

Robin M. Andrews

Robin M. Andrews

Virginia Tech

Chen-Yu Zhang

Chen-Yu Zhang

Nanjing University

Juan A. Pineda

Juan A. Pineda

Spanish National Research Council

Raymond G. Najjar

Raymond G. Najjar

Pennsylvania State University

Barry W. Ache

Barry W. Ache

University of Florida

Edouard Gentaz

Edouard Gentaz

University of Geneva

Richard N. Lalonde

Richard N. Lalonde

York University

Jed E. Rose

Jed E. Rose

Duke University

Peter Rudnai

Peter Rudnai

National Institutes of Health

Ying Lu

Ying Lu

Stanford University

Something went wrong. Please try again later.